Patents by Inventor William J Ehlhardt

William J Ehlhardt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cryptophycin compounds
    Patent number: 6680311
    Abstract: The present invention provides cryptophycin compounds of Formula I that are useful in the treatment of neoplasms.
    Type: Grant
    Filed: February 25, 1998
    Date of Patent: January 20, 2004
    Assignees: Eli Lilly and Company, Wayne State University, University of Hawaii
    Inventors: Rima S Al-Awar, William J Ehlhardt, Subbaraju V Gottumukkala, Michael J Martinelli, Eric D Moher, Richard E Moore, John E Munroe, Bryan H Norman, Vinod F Patel, James E Ray, Chuan Shih, John E Toth, Venkatraghavan Vasudevan
  • Antitumor compositions and methods of treatment
    Patent number: 6174921
    Abstract: This invention provides certain substituted benzenesulfonamide derivatives and methods for using them in the treatment of susceptible neoplasms in mammals. Also provided are certain novel pharmaceutical formulations employing these benzenesulfonamide derivatives in combination with a carrier.
    Type: Grant
    Filed: March 29, 1999
    Date of Patent: January 16, 2001
    Assignee: Eli Lilly and Company
    Inventors: William J Ehlhardt, James E Ray, John E Toth
  • Antitumor compositions and methods of treatment
    Patent number: 5827879
    Abstract: This invention provides certain substituted 2,3-dihydrobenzofurylsulfonamide derivatives and methods for using them in the treatment of susceptible neoplasms in mammals. Also provided are certain novel pharmaceutical formulations employing these benzenesulfonamide derivatives in combination with a carrier.
    Type: Grant
    Filed: October 3, 1997
    Date of Patent: October 27, 1998
    Assignee: Eli Lilly and Company
    Inventors: William J. Ehlhardt, James E. Ray, John E. Toth
  • Antitumor compositions and methods of treatment
    Patent number: 5262440
    Abstract: This invention provides the use of certain indenesulfonamide derivatives in the treatment of susceptible neoplasms in mammals. Also provided are certain novel indenesulfonamide derivatives and their pharmaceutical formulations.
    Type: Grant
    Filed: December 10, 1991
    Date of Patent: November 16, 1993
    Assignee: Eli Lilly and Company
    Inventors: William J. Ehlhardt, James E. Ray, John E. Toth
  • Antitumor compositions and methods
    Patent number: 5254582
    Abstract: This invention provides the use of N-[[(3,4-dichlorophenyl)amino]carbonyl]-2,3-dihydrobenzofuran-5-sulfonamid e, and pharmaceutically acceptable salts thereof, in the treatment of susceptible neoplasms in mammals. This invention further provides the novel aforementioned compound and its pharmaceutical formulations.
    Type: Grant
    Filed: February 5, 1992
    Date of Patent: October 19, 1993
    Assignee: Eli Lilly and Company
    Inventors: George B. Boder, William J. Ehlhardt, Gerald B. Grindey, John E. Toth, John F. Worzalla, John L. Zimmermann